Market Tracker

12/09 5:16pm ET

ImmuCell Corp (NASDAQ:ICCC)

6.27
Delayed Data
As of Dec 09
 +0.21 / +3.47%
Today’s Change
4.76
Today|||52-Week Range
8.29
-16.84%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.06
Today’s open6.12
Day’s range6.10 - 6.30
Volume2,190
Average volume (3 months)13,834
Market cap$29.4M
Dividend yield--
Data as of 3:59pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio31.4
Price/Sales2.32
Price/Book1.74

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...+0.00+0.98%
CANFCan Fite Biopharma L...+0.08+3.77%
PTIEPain Therapeutics In...+0.02+2.62%
HSGXHistogenics Corp-0.05-2.62%
Data as of 4:02pm ET, 12/09/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts